Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique program that collaborates with leading academic medical centers, the NIH, and foundations to speed the translation of novel targets to the clinic. A partnership with CTI may include collaborative use of Pfizer’s technologies, publishing rights, and financial awards in the form of milestone and royalty payments for successful programs, in addition to providing appropriate funds for carrying out the collaborative work.
Below are links to Pfizer CTI’s call for proposals for the Fall 2016 cycle. The deadline to submit pre-proposals to the Office of Technology Transfer is October 7, 2016.
To learn more about the program, please join us for a townhall session on September 15th at 11am in Greenberg Rm. 206, located in the CRC. If you are unable to join us you can also contact Manjula Donepudi or Kathleen Denis to learn more.
Requests for Proposals:
- Biotherapeutic and Small-Molecule Targets
- Alliance for Lupus Research
- Alzheimers Drug Discovery Foundation
- Crohns Colitis Foundation
- Jeffrey Modell Foundation